SCHEMBL6296757

SCHEMBL6296757

CCCC1=C(C#N)C(c2ccccc2C)c2c[nH]nc2N1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
ALOX15 P16050 9/20 0.43
HSD17B10 Q99714 7/20 0.43
KDM4E B2RXH2 4/20 0.43
MAPT P10636 5/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NR3C2 P08235 1/20 0.38
HPGD P15428 3/20 0.38
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
USP2 O75604 1/20 0.36
TP53 P04637 1/20 0.36
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
MEN1 O00255 1/20 0.34
BRCA1 P38398 1/20 0.34
HBB P68871 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6297368 0.89 HSD17B10 (0.36) ALDH1A1ALOX15HSD17B10KDM4EMAPT
SCHEMBL6297275 0.88 CDK1 (0.40) ALDH1A1ALOX15HSD17B10KDM4EMAPT
SCHEMBL6292466 0.88 ALDH1A1 (0.40) ALDH1A1ALOX15HSD17B10KDM4EMAPT
SCHEMBL6297230 0.87 ALDH1A1 (0.53) ALDH1A1ALOX15HSD17B10KDM4EMAPT
SCHEMBL6297233 0.86 ALDH1A1 (0.36) ALDH1A1ALOX15HSD17B10KDM4EMAPT
SCHEMBL6292239 0.86 NR3C2 (0.40) ALDH1A1ALOX15HSD17B10KDM4EMAPT
SCHEMBL6293389 0.85 NR3C2 (0.34) ALDH1A1ALOX15HSD17B10KDM4EMAPT
SCHEMBL6296586 0.84 ALDH1A1 (0.35) ALDH1A1ALOX15HSD17B10KDM4EMAPT
SCHEMBL6292345 0.83 CUL4A (0.47) ALDH1A1ALOX15HSD17B10KDM4EMAPT
SCHEMBL6760910 0.83 NR3C2 (0.33) ALDH1A1ALOX15HSD17B10KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6977262-B2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof MITSUBISHI PHARMA CORPORATION (JP) 2005-12-20 US disclosed
US-20040052822-A1 Dihydropyrazolopyridine compounds and pharmaceutical use thereof MITSUBISHI PHARMA CORPORATION (JP) 2004-03-18 US disclosed
WO-2002062795-A9 DIHYDROPYRAZOLOPYRIDINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF MITSUBISHI PHARMA CORP (JP) 2002-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040052822-A1 Dihydropyrazolopyridine compounds and pharmaceutical use thereof GSK3B, GSK3A, PYGB ALDH1A1 944/4885ALOX15 4522/4885HSD17B10 1715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.